Growth in this market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research.
The global Nerve Repair and Regeneration Market size is
projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020,
growing at a CAGR of 9.1% from 2020 to 2025.
Download
PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883
Market
Segmentation:-
By product, the nerve
repair market is segmented into neurostimulation and neuromodulation devices
and biomaterials. The neurostimulation and neuromodulation devices segment is
segment is expected to grow at the highest growth rate during the forecast
period. The large market share of this segment is driven mainly by rising
government expenditure for neurologic disorders, and favorable reimbursement.
Based on the
neurostimulation and neuromodulation application, the nerve regeneration market
is segmented the neurostimulation and neuromodulation devices market is
segmented into internal neurostimulation and neuromodulation applications and
external neurostimulation and neuromodulation applications. The internal
neurostimulation and neuromodulation segment is estimated to register the
highest CAGR during the forecast period.
Based on application,
the biomaterials market is segmented into direct nerve repair/neurorrhaphy,
nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment
accounted for the largest share of the market.
Recent
Developments:-
- In
2020, Medtronic received CE approval for InterStim Micro neurostimulator
and InterStim SureScan MRI leads — clearing the technologies for
commercial sale and clinical use in Europe
- In
2019, Boston Scientific received FDA approval for the Image Ready MRI for
its Vercise Gevia Deep Brain Stimulation System
- In
2020, LivaNova entered into partnership with Verily (US) for evaluation of
the effectiveness of Vagus Nerve Stimulation Therapy (VNS Therapy)
for difficult-to-treat Depression (DTD)
Regional
Analysis:-
The nerve repair
market is segmented into five major regions, namely, Europe, North America, the
Asia Pacific, Latin America, and Middle East & Africa. In 2019, North
America accounted for the largest share of the nerve repair and
regeneration industry, followed by Europe.
Speak To Analyst: – https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=883
Top
Key Players:-
Some of the major
players operating in the global nerve repair market include Medtronic, PLC.
(Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US),
AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK),
Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US),
Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US),
Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical
(Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies
GmbH(Germany), and GiMer Medical (Taiwan).
No comments:
Post a Comment